Literature DB >> 15067910

The role of ACE inhibitor therapy in treating cardiovascular disease.

Laura Flint1.   

Abstract

The first angiotensin-converting enzyme (ACE) inhibitors were introduced in 1981. They are used in the management of a variety of cardiovascular disorders and their role in hypertension, heart failure, managing asymptomatic and symptomatic left-ventricular dysfunction, post-myocardial infarction, stroke prevention, and diabetes is now well established. This is recognised in the National Service Framework for Coronary Heart Disease (Department of Health, 2000) and the guidelines from the British Hypertension Society (Ramsay et al, 1999). Nurses have a responsibility as part of the multidisciplinary team to have knowledge of various aspects of these drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067910

Source DB:  PubMed          Journal:  Nurs Times        ISSN: 0954-7762


  1 in total

1.  Novel angiotensin I-converting enzyme inhibitory peptides derived from an edible mushroom, Pleurotus cystidiosus O.K. Miller identified by LC-MS/MS.

Authors:  Ching Ching Lau; Noorlidah Abdullah; Adawiyah Suriza Shuib
Journal:  BMC Complement Altern Med       Date:  2013-11-11       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.